Reshma Rangwala Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Reshma Rangwala is EVP & Chief Medical Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 342,931 shares of KPTI, which is worth approximately $308,637. The most recent transaction as insider was on Apr 22, 2024, when has been sold 6,789 shares (Common Stock) at a price of $1.17 per share, resulting in proceeds of $7,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
343K
0%
3M change
116.73%
12M change
Total Value Held
$308,637
Reshma Rangwala Transaction History
Also insider at
RR
Reshma Rangwala
EVP & Chief Medical Officer
Houston, TX